Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study
Citation
Chappell , F M , Valdes Hernandez , M D C , Makin , S D , Shuler , K , Sakka , E , Dennis , M S , Armitage , P A , Munoz Maniega , S & Wardlaw , J M 2017 , ' Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study ' , Trials , vol. 18 , 78 . https://doi.org/10.1186/s13063-017-1825-7
Rights
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/)